This commentary considers two editorial pieces, written by Hajizadeh and Edmonds, and Lewis, which address universal pharmacare in Canada. The pieces focus on the social inequities of the existing system and the challenges of successful implementation. After identifying the significant strengths of both articles, this commentary then delves into the reasons why universal pharmacare may not be the solution, and identifies numerous thorny issues that will complicate the implementation of such a publicly funded program. Both discussions point to the need for caution and transparency going forward.
Lewis S. It won’t be easy: how to make universal pharmacare work in Canada. Int J Health Policy Manag. 2020;9(1):1-5. doi:10.15171/ijhpm.2019.82
Hajizadeh M, Edmonds S. Universal pharmacare in Canada: a prescription for equity in healthcare. Int J Health Policy Manag. 2020; In Press. doi:10.15171/ijhpm.2019.93
Law MR, Cheng L, Kolhatkar A, et al. The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey. CMAJ Open. 2018;6(1):E63-E70. doi:10.9778/cmajo.20180008
Acri née Lybecker, K. M. L. (2021). The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged; Comment on “Universal Pharmacare in Canada”. International Journal of Health Policy and Management, 10(3), 152-154. doi: 10.15171/ijhpm.2020.20
MLA
Kristina M. L. Acri née Lybecker. "The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged; Comment on “Universal Pharmacare in Canada”", International Journal of Health Policy and Management, 10, 3, 2021, 152-154. doi: 10.15171/ijhpm.2020.20
HARVARD
Acri née Lybecker, K. M. L. (2021). 'The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged; Comment on “Universal Pharmacare in Canada”', International Journal of Health Policy and Management, 10(3), pp. 152-154. doi: 10.15171/ijhpm.2020.20
VANCOUVER
Acri née Lybecker, K. M. L. The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged; Comment on “Universal Pharmacare in Canada”. International Journal of Health Policy and Management, 2021; 10(3): 152-154. doi: 10.15171/ijhpm.2020.20